Cefcapene

Uses your system voice; voice and rate in settings.

Snapshot

≈ 1 min read

Names in other languages

No names in other languages are held for this entry yet.

Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.

Cefcapene (INN) is a third-generation cephalosporin antibiotic. It was patented in 1985 and approved for medical use in 1997 in Japan, where it is sold under the Tradename Flomox by Shionogi & Co., Ltd. It is also approved and available as a generic in South Korea and China. It is known to cause severe hypocarnitinemia and associated serious hypoglycaemia, seizures, and encephalopathy in children.

Cefcapene (INN) is a third-generation cephalosporin antibiotic. It was patented in 1985 and approved for medical use in 1997 in Japan, where it is sold under the Tradename Flomox by Shionogi & Co., Ltd. It is also approved and available as a generic in South Korea and China. It is known to cause severe hypocarnitinemia and associated serious hypoglycaemia, seizures, and encephalopathy in children. ==References==

Text derived from https://en.wikipedia.org/w/index.php?oldid=1368057720 under CC BY-SA 4.0; modifications have been made.